Search Results (579)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Pancreatic cancer thromboembolic outcomes: rate of thrombosis after adenocarcinoma and non-adenocarcinoma pancreatic cancer surgery. | Academic Article |
Why?
|
| Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid apigenin in pancreatic cancer cell lines. | Academic Article |
Why?
|
| Management Controversies and Treatment Strategies for Borderline Resectable Pancreatic Cancer. | Academic Article |
Why?
|
| Pancreatic cancer: an update. | Academic Article |
Why?
|
| 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). | Academic Article |
Why?
|
| A family history of pancreatic cancer. | Academic Article |
Why?
|
| A Glimmer of Hope for Pancreatic Cancer. | Academic Article |
Why?
|
| A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. | Academic Article |
Why?
|
| A novel anti-pancreatic cancer agent, LY293111. | Academic Article |
Why?
|
| A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest. | Academic Article |
Why?
|
| A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer. | Academic Article |
Why?
|
| A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. | Academic Article |
Why?
|
| A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk. | Academic Article |
Why?
|
| Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. | Academic Article |
Why?
|
| Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? | Academic Article |
Why?
|